Literature DB >> 6869209

The hemodynamic consequences of cardiac arrhythmias: evaluation of the relative roles of abnormal atrioventricular sequencing, irregularity of ventricular rhythm and atrial fibrillation in a canine model.

M Naito, D David, E L Michelson, M Schaffenburg, L S Dreifus.   

Abstract

To evaluate the hemodynamic consequences of various cardiac arrhythmias, hemodynamic and angiographic studies were performed on 20 open-chest, atrioventricular (AV) heart-blocked dogs during various programmed pacing protocols. Protocols included AV pacing at intervals of 100 msec and -100 msec, ventricular (V) pacing during AV dissociation, and V pacing during atrial fibrillation (AF). In addition, the effects of regular versus irregular V pacing were also evaluated. During regular V pacing, cardiac output was optimal at an AV interval of 100 msec, but decreased by 25% at AV -100 msec and by 18% during both AV dissociation and AF. During irregular V cycles, cardiac output decreased further (e.g., by an additional 7% during AF). Pulmonary venous regurgitation was observed only during AV dissociation and during regular pacing at AV -100 msec. Notably, mitral valvular regurgitation was observed only during irregular V cycles, but not during regular V pacing, even in the presence of AV dissociation or AF. Using these methods it was possible to resolve some previously reported controversies regarding the relative importance of AV sequencing, atrial systole versus AF, regular versus irregular rhythms, as well as the possible contribution of mitral and/or pulmonary venous regurgitation to the adverse hemodynamics of various cardiac arrhythmias.

Entities:  

Mesh:

Year:  1983        PMID: 6869209     DOI: 10.1016/0002-8703(83)90194-1

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  35 in total

Review 1.  Mechanisms underlying the development of atrial arrhythmias in heart failure.

Authors:  Vias Markides; Nicholas S Peters
Journal:  Heart Fail Rev       Date:  2002-07       Impact factor: 4.214

Review 2.  Computational approaches to structural and functional analysis of plastocyanin and other blue copper proteins.

Authors:  F De Rienzo; R R Gabdoulline; R C Wade; M Sola; M C Menziani
Journal:  Cell Mol Life Sci       Date:  2004-05       Impact factor: 9.261

3.  Autonomic modulation of the atrial cycle length by the head up tilt test: non-invasive evaluation in patients with chronic atrial fibrillation.

Authors:  M P Ingemansson; M Holm; S B Olsson
Journal:  Heart       Date:  1998-07       Impact factor: 5.994

Review 4.  Atrial fibrillation in congestive heart failure.

Authors:  Steven A Lubitz; Emelia J Benjamin; Patrick T Ellinor
Journal:  Heart Fail Clin       Date:  2010-04       Impact factor: 3.179

5.  Atrial fibrillation begets trouble.

Authors:  J E Waktare; A J Camm
Journal:  Heart       Date:  1997-05       Impact factor: 5.994

6.  Importance of rate control or rate regulation for improving exercise capacity and quality of life in patients with permanent atrial fibrillation and normal left ventricular function: a randomised controlled study.

Authors:  T Levy; S Walker; M Mason; P Spurrell; S Rex; S Brant; V Paul
Journal:  Heart       Date:  2001-02       Impact factor: 5.994

Review 7.  Atrial fibrillation and heart failure: cause or effect?

Authors:  Christina Luong; Marion E Barnes; Teresa S M Tsang
Journal:  Curr Heart Fail Rep       Date:  2014-12

Review 8.  Atrial fibrillation and heart failure in the elderly.

Authors:  Pedram Kazemian; Gavin Oudit; Bodh I Jugdutt
Journal:  Heart Fail Rev       Date:  2012-09       Impact factor: 4.214

9.  Incident atrial fibrillation and risk of end-stage renal disease in adults with chronic kidney disease.

Authors:  Nisha Bansal; Dongjie Fan; Chi-yuan Hsu; Juan D Ordonez; Greg M Marcus; Alan S Go
Journal:  Circulation       Date:  2012-12-28       Impact factor: 29.690

Review 10.  Treatment Considerations for a Dual Epidemic of Atrial Fibrillation and Heart Failure.

Authors:  Parikshit S Sharma; David J Callans
Journal:  J Atr Fibrillation       Date:  2013-08-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.